Segall Bryant & Hamill LLC Cuts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Segall Bryant & Hamill LLC lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 16.5% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 83,311 shares of the medical device company's stock after selling 16,509 shares during the quarter. Segall Bryant & Hamill LLC's holdings in Cooper Companies were worth $7,027,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of COO. City Holding Co. purchased a new position in Cooper Companies during the 1st quarter worth $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies during the 4th quarter worth $38,000. Covestor Ltd boosted its holdings in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the last quarter. Larson Financial Group LLC boosted its holdings in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after acquiring an additional 664 shares during the last quarter. Finally, HM Payson & Co. boosted its holdings in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after acquiring an additional 532 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Down 1.8%

Cooper Companies stock traded down $1.31 during midday trading on Monday, reaching $71.32. The company's stock had a trading volume of 2,019,202 shares, compared to its average volume of 1,770,987. The stock's 50-day simple moving average is $74.03 and its 200-day simple moving average is $81.92. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The stock has a market capitalization of $14.26 billion, a P/E ratio of 34.62, a PEG ratio of 1.77 and a beta of 0.99. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. Cooper Companies's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $0.85 earnings per share. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analyst Weigh In

COO has been the topic of a number of research reports. Wells Fargo & Company lowered their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. UBS Group raised Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Needham & Company LLC upgraded Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a report on Tuesday, June 17th. Piper Sandler reiterated an "overweight" rating and issued a $105.00 price objective (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Wall Street Zen downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and a consensus target price of $97.20.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.